Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase 3 4Phase 1/2 3Phase 1 3Phase 2/3 2

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Non-Small-Cell Lung 127Breast Neoplasms 127Ovarian Neoplasms 79Fallopian Tube Neoplasms 45Lung Neoplasms 42Carcinoma, Ovarian Epithelial 30Uterine Cervical Neoplasms 27Parkinson Disease 4, Autosomal Dominant Lewy Body 27Endometrial Neoplasms 25Triple Negative Breast Neoplasms 23Neoplasms 20Neoplasm Metastasis 20Esophageal Neoplasms 19Stomach Neoplasms 18Esophageal Squamous Cell Carcinoma 14Adenocarcinoma of Lung 13Carcinoma 12Brenner Tumor 11Recurrence 10Urinary Bladder Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Head and Neck Neoplasms 8Peritoneal Neoplasms 7Inflammatory Breast Neoplasms 5Carcinoma, Squamous Cell 5Adenocarcinoma, Bronchiolo-Alveolar 5Adenocarcinoma 5Melanoma 4Carcinoma, Ductal, Breast 4Adenocarcinoma Of Esophagus 4

Interventions

Fluorouracil 16Cisplatin 11Radiotherapy 8Oxaliplatin 8Leucovorin 8Neoadjuvant Therapy 5Capecitabine 5Paclitaxel 4Nivolumab 4Docetaxel 4Trastuzumab 3Carboplatin 3dehydroftorafur 2Radiation 2Irinotecan 2Epirubicin 2Drug Therapy 2Chemotherapy, Adjuvant 2zolbetuximab 1zimberelimab 1zanidatamab 1trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1tislelizumab 1pertuzumab 1pembrolizumab 1gastrin immunogen 1Taxes 1Surgical Procedures, Operative 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Adenocarcinoma Of Esophagus × Paclitaxel × Clear all
NCT06356311 2026-02-27

TroFuse-015

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
450 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus

NCT01196390 2026-02-18

Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

National Cancer Institute (NCI)

Phase 3 Completed
203 enrolled 22 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT02509286 2024-05-08

ESOPEC

University Hospital Schleswig-Holstein

Phase 3 Active not recruiting
438 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT05188313 2022-06-24

TRAP-2

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 3 Recruiting
376 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡